• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

伴有下腔静脉肿瘤血栓的原发性肾小细胞神经内分泌癌:1例罕见病例报告

Primary Renal Small Cell Neuroendocrine Carcinoma With Inferior Vena Cava Tumor Thrombus: A Report of a Rare Case.

作者信息

Nguyen Duy T, Nguyen Hoang X, Hoang Phuc T

机构信息

Department of Urology, Binh Dan Hospital, Ho Chi Minh, VNM.

出版信息

Cureus. 2025 Jun 10;17(6):e85693. doi: 10.7759/cureus.85693. eCollection 2025 Jun.

DOI:10.7759/cureus.85693
PMID:40642700
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12243675/
Abstract

Primary renal neuroendocrine tumors (NETs) are exceedingly rare. Among these, small cell neuroendocrine carcinoma (SCNC) represents an aggressive and poorly differentiated subtype, with very few documented cases. We present a case of a 24-year-old male patient who presented with gross hematuria and flank pain. Imaging revealed a large right renal mass with a tumor thrombus extending into the inferior vena cava (IVC). The patient underwent radical nephrectomy, adrenalectomy, and IVC thrombectomy. Histopathological examination confirmed a high-grade small cell neuroendocrine carcinoma with extensive necrosis and vascular invasion. Immunohistochemistry was positive for CD56, synaptophysin, and a high Ki-67 index (~70%). Despite radical surgery and systemic chemotherapy with carboplatin and etoposide, the patient developed liver metastases within three months and succumbed to disease progression nine months postoperatively. This case underscores the rarity and aggressive nature of primary renal SCNC, the clinical significance of IVC tumor thrombus as a poor prognostic factor, and the rapid disease progression that can occur even in young patients. Multimodal therapy remains the mainstay of treatment, but the overall prognosis is poor. Further investigation into molecular characteristics and targeted therapies is urgently needed.

摘要

原发性肾神经内分泌肿瘤(NETs)极为罕见。其中,小细胞神经内分泌癌(SCNC)是一种侵袭性强且分化差的亚型,仅有极少病例记载。我们报告一例24岁男性患者,其表现为肉眼血尿和侧腹痛。影像学检查显示右肾有一巨大肿块,肿瘤血栓延伸至下腔静脉(IVC)。该患者接受了根治性肾切除术、肾上腺切除术及IVC血栓切除术。组织病理学检查证实为高级别小细胞神经内分泌癌,伴有广泛坏死和血管侵犯。免疫组化显示CD56、突触素阳性,Ki-67指数高(约70%)。尽管进行了根治性手术及卡铂和依托泊苷的全身化疗,但患者在三个月内出现肝转移,并于术后九个月因疾病进展死亡。该病例凸显了原发性肾SCNC的罕见性和侵袭性、IVC肿瘤血栓作为不良预后因素的临床意义,以及即使是年轻患者也可能出现的快速疾病进展。多模式治疗仍是主要治疗方法,但总体预后较差。迫切需要对分子特征和靶向治疗进行进一步研究。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/41a4/12243675/5bca405de4d7/cureus-0017-00000085693-i04.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/41a4/12243675/27c240d593a3/cureus-0017-00000085693-i01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/41a4/12243675/8c42a5f53629/cureus-0017-00000085693-i02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/41a4/12243675/eceeff7e28f2/cureus-0017-00000085693-i03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/41a4/12243675/5bca405de4d7/cureus-0017-00000085693-i04.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/41a4/12243675/27c240d593a3/cureus-0017-00000085693-i01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/41a4/12243675/8c42a5f53629/cureus-0017-00000085693-i02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/41a4/12243675/eceeff7e28f2/cureus-0017-00000085693-i03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/41a4/12243675/5bca405de4d7/cureus-0017-00000085693-i04.jpg

相似文献

1
Primary Renal Small Cell Neuroendocrine Carcinoma With Inferior Vena Cava Tumor Thrombus: A Report of a Rare Case.伴有下腔静脉肿瘤血栓的原发性肾小细胞神经内分泌癌:1例罕见病例报告
Cureus. 2025 Jun 10;17(6):e85693. doi: 10.7759/cureus.85693. eCollection 2025 Jun.
2
Multidisciplinary Surgical Management of Renal Cell Carcinoma With Inferior Vena Cava Tumor Thrombus: Perioperative and Oncological Outcomes.伴有下腔静脉瘤栓的肾细胞癌的多学科手术治疗:围手术期及肿瘤学结局
Cureus. 2025 Jun 7;17(6):e85527. doi: 10.7759/cureus.85527. eCollection 2025 Jun.
3
Impact of residual disease as a prognostic factor for survival in women with advanced epithelial ovarian cancer after primary surgery.原发性手术后晚期上皮性卵巢癌患者残留病灶对生存预后的影响。
Cochrane Database Syst Rev. 2022 Sep 26;9(9):CD015048. doi: 10.1002/14651858.CD015048.pub2.
4
A Decade of Robotic-Assisted Radical Nephrectomy with Inferior Vena Cava Thrombectomy: A Systematic Review and Meta-Analysis of Perioperative Outcomes.机器人辅助根治性肾切除术联合下腔静脉取栓术治疗 10 年:一项围手术期结局的系统评价和荟萃分析。
J Urol. 2022 Sep;208(3):542-560. doi: 10.1097/JU.0000000000002829. Epub 2022 Sep 1.
5
Transarterial (chemo)embolisation versus systemic chemotherapy for colorectal cancer liver metastases.经动脉(化疗)栓塞与全身化疗治疗结直肠癌肝转移。
Cochrane Database Syst Rev. 2024 Aug 9;8(8):CD012757. doi: 10.1002/14651858.CD012757.pub2.
6
Systemic treatments for metastatic cutaneous melanoma.转移性皮肤黑色素瘤的全身治疗
Cochrane Database Syst Rev. 2018 Feb 6;2(2):CD011123. doi: 10.1002/14651858.CD011123.pub2.
7
First-line lorlatinib treatment in a 19-year-old patient with ALK-rearranged pulmonary large-cell neuroendocrine carcinoma: a case report and literature review.19岁间变性淋巴瘤激酶(ALK)重排肺大细胞神经内分泌癌患者的一线劳拉替尼治疗:病例报告及文献综述
Anticancer Drugs. 2025 Jul 7. doi: 10.1097/CAD.0000000000001754.
8
Ultra-radical (extensive) surgery versus standard surgery for the primary cytoreduction of advanced epithelial ovarian cancer.超根治性(广泛)手术与标准手术治疗晚期上皮性卵巢癌的初步细胞减灭术。
Cochrane Database Syst Rev. 2022 Aug 30;8(8):CD007697. doi: 10.1002/14651858.CD007697.pub3.
9
Ablative and non-surgical therapies for early and very early hepatocellular carcinoma: a systematic review and network meta-analysis.早期和极早期肝细胞癌的消融和非手术治疗:系统评价和网络荟萃分析。
Health Technol Assess. 2023 Dec;27(29):1-172. doi: 10.3310/GK5221.
10
The effectiveness and cost-effectiveness of carmustine implants and temozolomide for the treatment of newly diagnosed high-grade glioma: a systematic review and economic evaluation.卡莫司汀植入剂与替莫唑胺治疗新诊断的高级别胶质瘤的有效性和成本效益:一项系统评价与经济学评估
Health Technol Assess. 2007 Nov;11(45):iii-iv, ix-221. doi: 10.3310/hta11450.

本文引用的文献

1
Atypical carcinoid of the primary kidney with retroperitoneal metastasis 15 years later: A case report and literature review.原发性肾非典型类癌15年后出现腹膜后转移:1例病例报告及文献复习
Urol Case Rep. 2024 Nov 21;58:102893. doi: 10.1016/j.eucr.2024.102893. eCollection 2025 Jan.
2
Pathogenesis, diagnosis and treatment of primary renal well-differentiated neuroendocrine tumors: a review of the literature.原发性肾高分化神经内分泌肿瘤的发病机制、诊断与治疗:文献综述
Front Oncol. 2024 Oct 4;14:1298559. doi: 10.3389/fonc.2024.1298559. eCollection 2024.
3
Prognostic factors and treatment impact on overall survival in patients with renal neuroendocrine tumour.
肾神经内分泌肿瘤患者的预后因素及治疗对总生存期的影响
BJUI Compass. 2024 Mar 11;5(6):576-584. doi: 10.1002/bco2.341. eCollection 2024 Jun.
4
Re: WHO Classification of Tumours, 5th Edition, Volume 8: Urinary and Male Genital Tumours.关于:《世界卫生组织肿瘤分类》第5版,第8卷:泌尿系统和男性生殖系统肿瘤。
Eur Urol. 2023 Sep;84(3):348-349. doi: 10.1016/j.eururo.2023.04.030. Epub 2023 May 10.
5
Primary Renal Carcinoid Tumor: Report of Two Cases.原发性肾类癌肿瘤:两例报告。
Perm J. 2020;24. doi: 10.7812/TPP/19.147. Epub 2020 Mar 13.
6
Primary Renal Well-differentiated Neuroendocrine Tumor Extending Into the Inferior Vena Cava.原发性肾脏高分化神经内分泌肿瘤延伸至下腔静脉。
Urology. 2020 Jan;135:e2-e4. doi: 10.1016/j.urology.2019.09.031. Epub 2019 Oct 5.
7
Primary Renal Neuroendocrine Tumour Presenting as an Enormous Cystic Lesion.表现为巨大囊性病变的原发性肾神经内分泌肿瘤
Turk Patoloji Derg. 2020;36(1):90-92. doi: 10.5146/tjpath.2017.01418.
8
Neuroendocrine tumors of the kidney: a single institution experience.肾神经内分泌肿瘤:单中心经验
Clin Genitourin Cancer. 2014 Dec;12(6):422-7. doi: 10.1016/j.clgc.2014.06.008. Epub 2014 Jun 11.
9
Primary renal carcinoid: treatment and prognosis.原发性肾类癌:治疗与预后。
Crit Rev Oncol Hematol. 2013 Sep;87(3):256-64. doi: 10.1016/j.critrevonc.2013.02.003. Epub 2013 Mar 9.
10
Review of renal carcinoid tumor with focus on clinical and pathobiological aspects.肾类癌肿瘤的临床与病理生物学研究进展
Histol Histopathol. 2013 Jan;28(1):15-21. doi: 10.14670/HH-28.15.